Overview

Success of Transitioning Uncontrolled Glaucoma Patients From Prior Mono or Adjunctive Therapy to DuoTrav

Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and efficacy of transitioning uncontrolled glaucoma patients to DuoTrav from other mono or adjunctive therapies.
Phase:
Phase 4
Details
Lead Sponsor:
Alcon Research
Treatments:
Cloprostenol
Maleic acid
Ophthalmic Solutions
Timolol
Travoprost